ロード中...
Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors
[Image: see text] Structure–activity relationships in a series of (2-oxo-1,4-benzodiazepin-3-yl)-succinamides identified highly potent inhibitors of γ-secretase mediated signaling of Notch1/2/3/4 receptors. On the basis of its robust in vivo efficacy at tolerated doses in Notch driven leukemia and s...
保存先:
出版年: | ACS Med Chem Lett |
---|---|
主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
American Chemical
Society
2015
|
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4434460/ https://ncbi.nlm.nih.gov/pubmed/26005526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.5b00001 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|